Mecka | $60,000,000 | (Jun 3, 2026)
Novellia | $18,000,000 | (Jun 3, 2026)
Plot | $10,000,000 | (Jun 3, 2026)
Avant Genomics
United States
- Charlottesville, Virginia
- 14/05/2026
- Unknown
- $3,000,000
Our mission at Avant Genomics is to empower early cancer detection and therapeutic monitoring through the automation of critical sample preparation steps, enabling precise and accessible diagnostics for better patient care.
- Industry Biotechnology Research
- Website https://www.avant-genomics.com/
- LinkedIn https://www.linkedin.com/company/avantgenomics/
Related People
Rachelle Turiello, PhDFounder
United States -
Greater Charlottesville Area
Specialist in bioanalytical microfluidics and analytical chemistry, with deep expertise in developing integrated genetic systems for clinical diagnostics and human forensic identification. As co-founder and CEO of Avant Genomics, I lead the translation of novel microfluidic technologies into deployable solutions for blood-based cancer detection. My work has earned recognition through multiple patents, peer-reviewed publications, and over 15 national and international awards. I’m passionate about cross-disciplinary collaboration that accelerates innovation—from prototyping to clinical application—and welcome opportunities to partner on advancing impactful diagnostic technologies.
KOSMOS | $5,000,000 | (Jun 3, 2026)
Phosio Corporation | $4,000,000 | (Jun 3, 2026)
StratusGrid | $3,000,000 | (Jun 3, 2026)
Tavo Biotherapeutics | $17,000,000 | (Jun 3, 2026)
Contraline | $92,500,000 | (Jun 3, 2026)
Gigaton | $26,000,000 | (Jun 3, 2026)
Westmag | $11,000,000 | (Jun 3, 2026)
Inherent | $50,000,000 | (Jun 2, 2026)
Voxmind | $735,203 | (Jun 2, 2026)